Evoked Resonant Neural Activity Supports Physiology-Guided Asleep Deep Brain Stimulation

For decades, doctors have treated severe Parkinson's disease by implanting tiny electrodes deep inside the brain. These devices deliver electrical pulses to specific, microscopic regions that control movement, effectively quieting the chaotic signals that cause tremors and stiffness. To place these wires correctly, surgeons traditionally rely on a combination of brain scans and the patient's own brain activity. In a standard procedure, the patient remains awake while the surgeon tests different spots; if the electrode is in the right place, the patient's tremor stops, and the brain's electrical signals show a distinct, rhythmic pattern. However, keeping a patient still and cooperative for hours is difficult, and many people are too anxious or frail to endure it. This has led to a rise in "asleep" surgeries, where patients are under general anesthesia. The problem is that anesthesia acts like a heavy blanket on the brain, silencing the very electrical rhythms surgeons use to find their way. Without these natural signals, doctors are left relying solely on static images, which can sometimes miss the precise, moving target of the motor circuit.

A team of researchers from the Mayo Clinic, Baylor College of Medicine, and the University of Houston set out to solve this problem by testing a different kind of signal. Instead of waiting for the brain to speak on its own, they asked if they could make the brain speak back. They focused on a phenomenon called evoked resonant neural activity, or ERNA. This is not a spontaneous rhythm but a response that happens when the electrode sends a small, controlled electrical pulse and the brain circuitry answers with a specific, measurable echo. The researchers wanted to know if this echo remains clear and useful even when the patient is asleep and their natural brain waves are suppressed by anesthesia. They studied 45 patients with Parkinson's disease who underwent surgery to place electrodes in two different deep brain targets: the subthalamic nucleus and the globus pallidus internus. These targets are small, tightly packed structures, and finding the exact motor territory within them is like searching for a specific room in a crowded house without being able to hear the people inside.

The team recorded electrical activity from the electrodes in both awake and anesthetized states. As expected, they found that under general anesthesia, the natural, spontaneous rhythms that usually guide the surgery became very faint and difficult to detect. The brain's own chatter was effectively silenced. However, when the researchers sent their electrical pulses to the brain, the response was different. While the strength of the echo was slightly weaker under anesthesia, it did not disappear. By increasing the strength of the electrical pulse just a little, they could restore the signal to a loud, clear level. Crucially, the location of this strongest echo did not change. Whether the patient was awake or asleep, the electrode contact that picked up the biggest response was always the same one. This suggests that the brain's circuitry is still responding in a predictable way, even when the patient is unconscious.

The researchers then checked if this echo pointed to the right place. They compared the location of the strongest ERNA signal against the locations where the natural rhythms were strongest in awake patients, and against the known anatomical maps of the brain. They found that the echo consistently appeared in the same motor territories that are known to be the best targets for treatment. In fact, the signal remained so precise under anesthesia that it was actually better at identifying the correct target than the natural rhythms were when the patient was asleep. The study also looked at the long-term success of the surgery. They found that the electrode contacts which produced the strongest echo during the operation were the same contacts that doctors later programmed to give patients the best relief from symptoms and the widest range of safe settings. This link between the strength of the echo and the clinical benefit held true for both the awake and asleep groups.

One notable detail emerged regarding the nature of the signal itself. While the location and strength of the echo were reliable, the speed of the response slowed down slightly under anesthesia. The researchers interpret this as a sign that the anesthesia is affecting the timing of the neural loops, making the circuit react a bit more slowly, but not breaking the connection. This finding is important because it confirms that the signal is still coming from the same network, just operating at a different pace. The study did not claim that this method is a perfect replacement for all other techniques, nor did it prove that using this signal alone guarantees a better outcome for every patient. Instead, the results suggest that this evoked response is a robust tool that can fill the gap left by anesthesia. It offers a way to verify that the electrode is in the right place using the brain's own functional response, rather than just its shape on a scan.

The implications of this work are practical for the future of neurosurgery. If surgeons can rely on this evoked signal, they may be able to perform more procedures while patients are asleep, reducing the stress and risk associated with staying awake during a delicate operation. It also offers a way to double-check the placement of the electrode before the surgery is finished, ensuring that the device is positioned to engage the motor circuits effectively. The researchers emphasize that this approach is meant to work alongside modern imaging, not replace it. By adding a layer of functional information to the anatomical map, doctors can gain a clearer picture of what the brain is actually doing at the moment of implantation. While further studies are needed to confirm that this method improves patient outcomes in the long run, the current findings provide a strong foundation for using the brain's own echo to guide the path to better treatment.